Table 5.
Comparison of physician-reported outcome after RT and PRO (n = 38). In both groups, only new and worsened symptoms after RT are listed
| CTCAE grade | Physician-reported after RT | PRO | ||||
|---|---|---|---|---|---|---|
| 1/2 | 3 | 4 | 1/2 | 3 | 4 | |
| Pain | 9 (24%) | – | – | 16 (42%) | – | – |
| Fatigue | 10 (26%) | – | – | 25 (66%) | – | – |
| Nausea/vomiting | 1 | – | – | 4 (11%) | – | – |
| Dermatitis | 1 (3%) | – | – | 4 (11%) | 1 (3%) | – |
| Hyperpigmentation | 2 (5%) | – | – | 2 (5%) | – | – |
| Edema | 4 (11%) | – | – | 14 (37%) | – | – |
| Osteonecrosis, rib fracture | – | – | – | – | – | – |
| Sensory deficits | – | – | – | 15 (39%) | 1 (3%) | 1 (3%) |
| Motor deficits | – | – | – | 13 (34%) | 2 (5%) | |
| Weight loss | 4 (11%) | – | – | 9 (24%) | 1 (3%) | – |
| Fibrosis | 17 (45%) | – | – | – | – | – |
| Pneumonitis | 10 (26%) | – | – | – | – | – |
| Dysphagia | 2 (5%) | – | – | 14 (37%) | 1 (3%) | – |
| Dyspnea | 16 (42%) | – | – | 18 (47%) | 4 (11%) | 2 (5%) |
| Cough | 14 (37%) | – | – | 24 (63%) | 1 (3%) | – |
| Xerostomia | 1 (3%) | – | – | 22 (58%) | – | – |
| Dysphonia | – | – | – | 12 (32%) | 1 (3%) | – |
RT Radiotherapy, PRO Patient-reported outcome, CTCAE Common Terminology Criteria for Adverse Events